DCM
RVMD icon

Driehaus Capital Management’s Revolution Medicines RVMD Stock Holding History

Driehaus Capital Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.7M Buy
+88,913
New +$13M 0.1% 246
2023
Q4 		– Sell
-218,153
Closed -$6.04M – 448
2023
Q3 		$6.04M Sell
218,153
-490
-0.2% -$14.5K 0.08% 269
2023
Q2 		$5.85M Buy
218,643
+7,875
+4% +$193K 0.07% 263
2023
Q1 		$4.57M Sell
210,768
-5,539
-3% -$136K 0.06% 301
2022
Q4 		$5.15M Sell
216,307
-2,890
-1% -$61.4K 0.08% 263
2022
Q3 		$4.32M Buy
+219,197
New +$4.82M 0.07% 282
2021
Q2 		– Sell
-205,788
Closed -$9.44M – 510
2021
Q1 		$9.44M Buy
+205,788
New +$9.23M 0.14% 214

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Driehaus Capital Management's RVMD Position: Q2 2026 in Review

Driehaus Capital Management opened a new position in Revolution Medicines (RVMD) in Q2 2026: 88,913 shares worth $16.7M. The stake represents 0.1% of the portfolio and ranks #246 among its holdings. This is a return to the name: Driehaus Capital Management previously reported a position in RVMD as recently as Q3 2023.

Driehaus Capital Management first reported a position in RVMD in Q1 2021 and has held it in 7 quarters since. 691 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Driehaus Capital Management held 88,913 shares of Revolution Medicines worth $16.7M as of Q2 2026.
  • Revolution Medicines was a new Driehaus Capital Management position in Q2 2026.
  • Revolution Medicines made up 0.1% of Driehaus Capital Management's portfolio in Q2 2026, its #246 holding.
  • Driehaus Capital Management first reported a position in Revolution Medicines in Q1 2021 and has held it in 7 quarters since.
  • 691 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Driehaus Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.